8-K: Selectis Health Subsidiaries Enter Agreements to Sell Four Skilled Nursing Facilities for $27 Million
Asset Sale Announcement
Selectis Health's subsidiaries have agreed to sell four skilled nursing facilities in Georgia for an aggregate purchase price of $27 million, subject to customary adjustments and conditions.
Summary
- Selectis Health, through its subsidiaries, has entered into definitive agreements to sell four skilled nursing facilities located in Georgia.
- The aggregate purchase price for the facilities is $27 million, subject to prorations, holdbacks, and adjustments.
- The transactions are contingent upon customary conditions, including satisfactory completion of due diligence.
- The facilities are operated by separate, wholly-owned subsidiaries of Selectis Health.
- Concurrently with the sale agreements, the operating subsidiaries entered into Operations Transfer Agreements (OTAs) with entities affiliated with the purchaser to govern the transfer of skilled nursing operations.
- An initial deposit of $500,000 has been made by the purchaser into an escrow account, governed by an Escrow Agreement.
- The Sparta Facility is subject to a separate Purchase and Sale Agreement (PSA) due to the purchaser's intent to assume the HUD loan secured by the facility.
Sentiment
Score: 6
Explanation: Neutral sentiment. The announcement details a sale of assets, which could be positive or negative depending on the company's overall strategy and the terms of the deal. The lack of explicit forward-looking statements or management commentary makes it difficult to assess the overall impact.
Positives
- The sale will provide Selectis Health with $27 million in capital.
- The Operations Transfer Agreements (OTAs) are designed to ensure a smooth transition of operations to the new operators.
- The purchaser is assuming the HUD loan associated with the Sparta Facility, relieving Selectis Health of this liability.
Negatives
- The transactions are subject to numerous conditions, and there is no assurance that they will be consummated.
- The sale agreements include customary holdbacks and adjustments, which could reduce the final proceeds received by Selectis Health.
- The company is selling assets.
Risks
- The transactions may not close if the purchaser's due diligence is unsatisfactory or if other closing conditions are not met.
- The final purchase price is subject to adjustments, which could reduce the proceeds received by Selectis Health.
- The company is selling assets.
Future Outlook
The consummation of the PSAs is contingent upon numerous conditions, and there can be no assurance that the PSAs will be consummated.
Industry Context
The skilled nursing facility market is undergoing consolidation, with larger operators acquiring smaller facilities to achieve economies of scale. This transaction reflects this trend.
Comparison to Industry Standards
- The sale of skilled nursing facilities is common in the healthcare industry, with valuations typically based on a multiple of revenue or EBITDA.
- Comparable transactions include the sale of Brookdale Senior Living's skilled nursing facilities to HCR ManorCare and the acquisition of Kindred Healthcare by TPG Capital, Welsh, Carson, Anderson & Stowe, and Humana.
- The $27 million purchase price for four facilities is within the typical range for such transactions, but the specific terms and conditions will determine the ultimate value to Selectis Health.
Stakeholder Impact
- Shareholders: Potential impact on the company's financial position and strategic direction.
- Employees: Potential changes in employment terms and conditions as the facilities transition to new operators.
- Residents: Potential changes in the quality of care and services provided at the facilities.
- Suppliers: Potential changes in vendor relationships as the facilities transition to new operators.
Next Steps
- Satisfying the conditions for closing the Purchase and Sale Agreements.
- Obtaining regulatory approvals for the transfer of ownership and operations.
- Completing the transfer of assets and operations to the new operators.
Key Dates
| Date | Description |
|---|---|
| February 7, 2025 | Effective date of the Purchase and Sale Agreements and Operations Transfer Agreements |
| February 12, 2025 | Date of report |
| February 14, 2025 | Due Diligence Period ends |
| April 1, 2025 | Target Closing Date |
| May 1, 2025 | End Date for Closing |
| June 2, 2025 | Extended Closing Date |
| October 31, 2025 | Date before which HUD TPA approval must be received |
| December 31, 2025 | Extended End Date for Closing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.